TP53 and cancer: Using this strategy in the first systematic study of germline and somatic ADO in a cancer related gene, we report that ADOs resulted in missing ~7% pathogenic TP53 germline mutations in Li Fraumeni syndrome and ~28% somatic TP53 mutation in oral cancer tissues.